FDA Issues Emergency Use Authorization for PCR-based A(H7N9) Influenza Virus Assay | GenomeWeb

NEW YORK (GenomeWeb News) – The US Food and Drug Administration this week issued an emergency use authorization, or EUA, for a Centers for Disease Control and Prevention assay for the detection of influenza A virus subtype H7N9.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.